Clinical trial
Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions
NCT01305356
Study timeline
Study start (actual)2011-03-01Date precision: month
Registry last updated2018-12-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Degenerative Joint Diseaseunresolved
Congenital Deformityunresolved
Arthritisunresolved
Osteoarthritisunresolved
Rheumatoid Arthritisunresolved
Interventions
Autologous bone graftPROCEDURE
Sponsors & collaborators
BioMimetic Therapeuticslead sponsor
Mapped research locations
TucsonArizona, United States2New YorkNew York, United States1HoustonTexas, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1TorontoOntario, Canada1San FranciscoCalifornia, United States1ClevelandOhio, United States1ColumbusOhio, United States1Oklahoma CityOklahoma, United States1RochesterNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01305356 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.